Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Primary Care Reports



  • The Silent Epidemic: Hepatitis C Virus

    Hepatitis C accounts for a significant burden of disease. There are many barriers to the eradication of hepatitis C virus (HCV), from infection identification to treatment, making it a very complex public health concern. Unfortunately, no vaccine for HCV exists yet, and development proves difficult because of the overwhelming genetic diversity. HCV can be treated by a patient’s primary care physician; this group is instrumental in screening for and treating hepatitis C.

  • Identifying and Responding to Potential Cases of Human Trafficking in the Primary Care Setting

    This paper aims to equip the primary care provider with the knowledge and skills to identify and respond effectively to potential cases of human trafficking in a primary care setting. When seeking care, individuals caught up in trafficking are most likely to present to an emergency room or urgent care, but about 40% go to private practices or clinics. An astute primary care provider has a unique opportunity to educate, intervene, or assist a patient at this point, should the individual be looking for this type of intervention.

  • An Update on What Is New During the 2023-2024 Flu Season

    As the fall and winter months descend in the Northern Hemisphere, it is time for healthcare providers to focus on preventing and treating the influenza virus. The Centers for Disease Control and Prevention estimates from the current flu season (Oct. 1, 2023, to present) suggest 1 million cases of flu illness and between 5,000 to 12,000 hospitalizations. Healthcare practitioners on the frontline must have current knowledge of prevention and treatment strategies.

  • The Many Controversies of Cannabidiol

    Current trends in cannabinoid research, federal and state cannabis legislation, multi-sourced information, as well as misinformation, all drive consumer interest in cannabidiol (CBD). With the increased use of CBD products, increased incidents of poisonings are being reported. With confusion on policy, on potential benefits and harms, and on long-term chronic effects often seen with excessive use, determining the facts is increasingly problematic for healthcare practitioners and consumers. These issues prioritize the need for clinicians, especially in primary care, to stay current on developments related to CBD and other cannabinoids.

  • Diagnosing and Managing Complications of Alcohol-Related Liver Disease

    Alcohol, or ethanol, is the most frequently misused drug across the world. It is estimated that, in the United States, 67.3% of the population consumes alcohol, and 7.4% of the population meets diagnostic criteria for substance use disorder. Alcohol use is the leading cause of liver disease and the second most common reason for liver transplantation in the United States. This article discusses the complications seen in alcohol-related liver disease.

  • Chronic Obstructive Pulmonary Disease Update for Primary Care Providers

    The Global Initiative for Chronic Obstructive Lung Disease 2023 report defines chronic obstructive pulmonary disease (COPD) as a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production, and/or exacerbations) caused by abnormalities of the airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that result in persistent, often progressive, airflow obstruction. COPD was the fourth leading cause of death in the United States in 2018 and is estimated to be responsible for 3 million deaths annually around the world, with expected increases to 5.4 million annual deaths from COPD and related conditions by 2060.

  • Preventing and Reversing Cardiovascular Disease Through Lifestyle Modification

    Cardiovascular disease (CVD) is the leading cause of death globally and in the United States. Identifying and targeting cardiovascular risk factors is essential for the prevention and long-term management of CVD. Traditionally, factors for the onset and progression of CVD were thought to be mostly genetic. It is now well established that several of these factors are lifestyle mediated. Behavioral changes significantly influence the interplay between a healthy lifestyle and the genetic risk of heart disease. To further understand the challenges with preventing and reversing CVD, providers need to consider the alarming prevalence of risk factors among the U.S. population.

  • Endometriosis and the Gut Microbiome: Nutritional Prospects in the Treatment of a Chronic Disease

    Endometriosis is characterized by the presence of endometrial glands and stroma in any extrauterine site, such as the ovary, fallopian tubes, pelvic peritoneum, rectovaginal space, bowel, and, rarely, lungs and brain. Standard treatment of endometriosis may involve the use of pain relievers such as nonsteroidal anti-inflammatory drugs, hormonal therapy and modulators, and/or surgical removal of endometriotic tissue. On average, women seek consultation from three different healthcare providers over several years to receive a diagnosis of endometriosis. The delay in care results in significant long-term morbidity.

  • Patient Advocates Launch National Diabetes Treatment Recognition Program

    Hospitals can be evaluated based on their care for patients with diabetes during admission, stay, and discharge.

  • Physician Group Says to Start Colon Cancer Screening at Age 50 Years

    Patient advocates push back, standing by other recommendations that set the age at 45 years.